It’s our people that make the difference
Our partners and attorneys are highly qualified and highly experienced to advise you in all areas of Intellectual Property law. We advise start-ups, SMEs, and multinational corporations and ensure that your inventions, brands and designs are expertly protected.
Bosch have developed a rapid test that can diagnose COVID-19 coronavirus infection in patients in under two and a half hours, from sample time to result.
COVID-19 is spreading at an exponential rate across the world. An ability to quickly, easily, and reliably diagnose the virus is vital in tackling this growth and getting on top of the escalating situation. Bosch’s new, fully automated rapid test runs on their Vivalytic analysis device and will enable hospitals, laboratories, health care centres, etc, to make crucial diagnoses, fast, and on-site, with no need to send samples away.
Dr. Volkmar Denner, chairman of the board of management of Robert Bosch GmbH says the new tester “will speed up the identification and isolation of infected patients,”
“Time is of the essence in the fight against coronavirus. Reliable, rapid diagnosis directly on site with no back and forth — that is the great advantage of our solution, which we see as another example of technology that is ‘Invented for life,’”
The test is one of the world’s first fully automated molecular diagnostic tests that can be used directly by all medical institutions.
The newly developed test will be available in Germany starting in April, with other markets in Europe and elsewhere to follow.
Read the full announcement made by Bosch here: https://www.bosch.com/stories/vivalytic-rapid-test-for-covid-19/
If you’d like discuss this topic, please contact the writer, or another member of our team.
Category: Latest Insights | Published: | Read more
